EMA to review safety of growth hormone-based medicines after study (Bloomberg, 10 December 2010)

10 Dec 2010


A study has suggested that drugs containing analogues of human growth hormone could increase the risk of death during childhood, prompting the European Medicines Agency to conduct a review of the drugs' safety.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story